Eurofins MWG Operon Launches Ion Proton Sequencing Services - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Eurofins MWG Operon Launches Ion Proton Sequencing Services



Eurofins MWG Operon has expanded its exome sequencing services with the Ion Proton Next Generation Sequencer.
Certification for Ion AmpliSeq Exome sequencing was also awarded after joining Life Technologies Corporation's Ion AmpliSeq Exome Certified Service Provider program (CSP). Using Life Technologies proprietary approach, consisting of the Ion AmpliSeq Exome Kit, the Ion Proton Sequencer and Ion Reporter Software, provides researchers with a fast, and cost-effective exome sequencing solution available with flexible throughput, according to the company.

Source: Eurofins MWG Operon

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here